Literature DB >> 20850978

Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor.

Laura De Luca1, Stefania Ferro, Rosaria Gitto, Maria Letizia Barreca, Stefano Agnello, Frauke Christ, Zeger Debyser, Alba Chimirri.   

Abstract

The search of small molecules as protein-protein interaction inhibitors represents a new attractive strategy to develop anti-HIV-1 agents. We previously reported a computational study that led to the discovery of new inhibitors of the interaction between enzyme HIV-1 integrase (IN) and the nuclear protein lens epithelium growth factor LEDGF/p75.(1) Herein, we describe new findings about the binding site of LEDGF/p75 on IN employing a different computational approach. In this way further structural requirements, helpful to disrupt LEDGF/p75-IN binding, have been identified. The main result of this work was the exploration of a relevant hydrophobic region. So we planned the introduction of suitable and simple chemical modifications on our previously reported 'hit' and the new synthesized compounds were subjected to biological tests. The results obtained demonstrate that the hydrophobic pocket could play a key role in improving inhibitory efficacy thus opening new suggestions to design active ligands.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850978     DOI: 10.1016/j.bmc.2010.08.051

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  LEDGF (p75) promotes DNA-end resection and homologous recombination.

Authors:  Mads Daugaard; Annika Baude; Kasper Fugger; Lou Klitgaard Povlsen; Halfdan Beck; Claus Storgaard Sørensen; Nikolaj H T Petersen; Poul H B Sorensen; Claudia Lukas; Jiri Bartek; Jiri Lukas; Mikkel Rohde; Marja Jäättelä
Journal:  Nat Struct Mol Biol       Date:  2012-07-08       Impact factor: 15.369

2.  Getting pharmaceutical R&D back on target.

Authors:  Mark E Bunnage
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040

3.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

4.  Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking.

Authors:  Guoping Hu; Xi Li; Xianqiang Sun; Weiqiang Lu; Guixia Liu; Jin Huang; Xu Shen; Yun Tang
Journal:  J Mol Model       Date:  2012-06-26       Impact factor: 1.810

5.  The molecular biology of HIV integrase.

Authors:  Robert Craigie
Journal:  Future Virol       Date:  2012-07       Impact factor: 1.831

6.  Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.

Authors:  Xing Fan; Feng-Hua Zhang; Rasha I Al-Safi; Li-Fan Zeng; Yumna Shabaik; Bikash Debnath; Tino W Sanchez; Srinivas Odde; Nouri Neamati; Ya-Qiu Long
Journal:  Bioorg Med Chem       Date:  2011-06-26       Impact factor: 3.641

7.  Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.

Authors:  Erik Serrao; Bikash Debnath; Hiroyuki Otake; Yuting Kuang; Frauke Christ; Zeger Debyser; Nouri Neamati
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

8.  Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions.

Authors:  Tino Wilson Sanchez; Bikash Debnath; Frauke Christ; Hiroyuki Otake; Zeger Debyser; Nouri Neamati
Journal:  Bioorg Med Chem       Date:  2012-12-20       Impact factor: 3.641

9.  A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.

Authors:  Disha Patel; Janet Antwi; Pratibha C Koneru; Erik Serrao; Stefano Forli; Jacques J Kessl; Lei Feng; Nanjie Deng; Ronald M Levy; James R Fuchs; Arthur J Olson; Alan N Engelman; Joseph D Bauman; Mamuka Kvaratskhelia; Eddy Arnold
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

Review 10.  Novel therapeutic strategies targeting HIV integrase.

Authors:  Peter K Quashie; Richard D Sloan; Mark A Wainberg
Journal:  BMC Med       Date:  2012-04-12       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.